1 Department of Urology, Urological Research Institute, San Raffaele Scientific Institute, Vita-Salute University , Milan, Italy .
J Endourol. 2014 Apr;28(4):416-23. doi: 10.1089/end.2013.0571. Epub 2014 Jan 9.
The European Association of Urology (EAU) guidelines recommend to perform extended pelvic lymph node dissection (ePLND) in all patients with a risk of lymph node invasion (LNI) higher than 5% estimated by the updated Briganti nomogram. However, this model has been developed in patients exclusively treated with open radical prostatectomy. No study has specifically assessed the accuracy of this model among men treated with robot-assisted radical prostatectomy (RARP). We hypothesized that EAU indications for PLND are accurate also among patients treated with RARP.
We evaluated 615 patients treated with RARP and PLND between 2006 and 2012 at a single tertiary referral center. The predictive accuracy of the nomogram was quantified using the receiver operating characteristic-derived area under the curve, the calibration plot method, and decision curve analyses.
Median of lymph nodes (LNs) removed was 9 (interquartile range: 6-13). The rate of LNI was 5%. External validation of the Briganti nomogram showed good accuracy (81.8%). A nomogram-derived cutoff of 5% would allow the avoidance of 75% of PLND at the cost of missing of 19.4% of patients with LNI. When the same analyses were repeated in men with at least 10 and 15 LNs removed, the 5% cutoff was associated with a reduction in PLND and with an LNI missing rates of 67.6% and 59.3% and 17.4% and 6.2%, respectively. Similarly, the prediction accuracy increased to 81.2% and 85.3%, respectively. The decision curve analysis showed an increase in the net-benefit in the prediction range between 2.5% and 54%.
We report the first validation of the EAU guideline recommendation for PLND among patients exclusively treated with RARP. We demonstrated that the accuracy of Briganti nomogram is high, but the proposed 5% cutoff is valid only in the presence of adequate ePLND.
欧洲泌尿外科学会(EAU)指南建议对所有经更新的 Briganti 列线图估计有淋巴结侵犯(LNI)风险大于 5%的患者进行扩大盆腔淋巴结清扫术(ePLND)。然而,该模型仅在接受开放性根治性前列腺切除术的患者中得到了发展。尚无研究专门评估该模型在接受机器人辅助根治性前列腺切除术(RARP)治疗的男性中的准确性。我们假设在接受 RARP 治疗的患者中,EAU 对 PLND 的适应证也是准确的。
我们评估了 2006 年至 2012 年期间在一家单一的三级转诊中心接受 RARP 和 PLND 治疗的 615 名患者。通过受试者工作特征曲线下面积的接收者操作特征曲线、校准图方法和决策曲线分析来量化列线图的预测准确性。
中位淋巴结(LN)切除数为 9(四分位距:6-13)。LNI 发生率为 5%。Briganti 列线图的外部验证显示了良好的准确性(81.8%)。列线图衍生的 5%截断值可避免 75%的 PLND,但会遗漏 19.4%的 LNI 患者。当在至少切除 10 个和 15 个 LN 的男性中重复进行相同的分析时,5%的截断值与 PLND 的减少以及 LNI 的漏诊率 67.6%和 59.3%以及 17.4%和 6.2%相关,分别。同样,预测准确性分别提高到 81.2%和 85.3%。决策曲线分析显示,在 2.5%至 54%的预测范围内,净收益增加。
我们报告了首次对仅接受 RARP 治疗的患者进行的 EAU 指南推荐 PLND 的验证。我们证明了 Briganti 列线图的准确性很高,但提出的 5%截断值仅在进行充分的 ePLND 时有效。